Pharmaceutical compositions
AssigneeCipla Limited
InventorsGeena Malhotra, Shrinivas Madhukar Purandare, Amar Lulla
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for inhalation comprising R (+) budesonide and one or more bronchodilators, and, optionally, one or more pharmaceutically acceptable excipients is described.
Claims22
A pharmaceutical composition for use in treatment of at least one of asthma and COPD comprising a fixed dose combination consisting of R-(+)-budesonide and arformoterol, and, optionally, one or more pharmaceutically acceptable excipients,
- wherein R (+) budesonide is present in an amount ranging from 80-640 mcg and arformoterol is present in an amount ranging from 2.4-20.4 mcg;
- and,
- wherein said fixed dose combination of the R-(+)-budesonide and arformoterol is formulated for administration once per day.
A pharmaceutical composition for use in treatment of at least one of asthma and COPD comprising a fixed dose combination consisting of R-(+)-budesonide and arformoterol, and, optionally, one or more pharmaceutically acceptable excipients,
- formulated in a metered multi-dose container, wherein the metered multi-dose container contains (quantity/container):
- R (+) Budesonide 16 mg, and
- Arformoterol tartarate 0.48 mg;
- wherein said fixed dose combination of the R-(+)-budesonide and arformoterol is formulated for administration once per day.
Dependencies are inferred from the claim text.